<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14-antioxidants-09-00573">
 <label>14.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Takayama</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Wada</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Tsutamoto</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ohnishi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Fujii</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Isono</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Horie</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Contribution of Vascular NAD(P)H Oxidase to Endothelial Dysfunction in Heart Failure and the Therapeutic Effects of HMG-CoA Reductase Inhibitor</article-title>
  <source>Circ. J.</source>
  <year>2004</year>
  <volume>68</volume>
  <fpage>1067</fpage>
  <lpage>1075</lpage>
  <pub-id pub-id-type="doi">10.1253/circj.68.1067</pub-id>
  <pub-id pub-id-type="pmid">15502390</pub-id>
 </element-citation>
</ref>
